Hikma`s Generic Sodium Acetate Receives Approval in the U.S.
Fresenius Kabi USA`s Generic Kabilyte Receives Approval in the US
Health Canada Issues Recall of Fresenius Kabi Canada Sodium Acetate Injection, USP: Particulate matter
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi USA is voluntarily recalling seven lots of Sodium Acetate Injection, USP, 400 mEq/100 mL (4 mEq/mL), 100 mL fill in a 100 mL vial to the user level due to the presence of particulate matter found in reserve and/or stability sample vials. Microscopic and elemental analyses determined the presence of particulates composed of carbon and oxygen with varying amounts of iron and trace amounts of sodium, silicon, chromium, aluminum and cellulose.
Fresenius Kabi Issues Voluntary Recall of Sodium Acetate Injection, USP Due to the Presence of Particulate Matter
MINNETONKA, Minn.--(BUSINESS WIRE)--Milla Pharmaceuticals, a subsidiary of the Alter Pharma Group, announced that it has received abbreviated new drug application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for its generic version of Sodium Acetate Injection 2MEQ/mL.
Milla `s Generic Sodium Acetate Receives Approval In US
Enforcement Report - Week of May 16, 2018
Fresenius Kabi USA’s Generic Sodium Acetate Receives Approval In US
How many times has Hospira, now owned by Pfizer, recalled some form of dextrose in the last four years? Twenty-three times, roughly one recall every two months on average. But its latest recall of 25% dextrose injection is different because this product is for infants.